About Andrew Austin
Andrew leads our London dispute resolution practice. He handles commercial disputes, consumer protection matters, and product liability and data privacy litigation within the tech, life sciences, consumer goods and retail sectors. He also helps clients manage regulatory risks and develop and implement cross-border regulatory strategies.
He has acted on some of the most complex consumer mass claims of the last decade and is particularly focused on coordinating the defence of such litigation across across multiple markets. He has a particular specialism in product liability defence work, and is ranked by Chambers (2023) for Life Sciences - Product Liability (band 1) and Product Liability: Mainly Defendant (band 3).
Andrew advises clients on the application of product liability rules to emerging tech, and in May 2018 was appointed to the European Commission’s Expert Group on Liability and New Technologies. In December 2019, he joined the Commission's subgroup on AI and product safety. Another area of focus, in recent years, has been the growing importance of consumer law and governments’ increasing scrutiny of consumer-facing business practices. For example, he is currently advising clients on the UK's new consumer protection enforcement regime under the Digital Markets, Competition and Consumers Bill.
Andrew was formerly the co-head of the firm’s Consumer and Healthcare sector group and our UK graduate recruitment partner. He is closely involved with Halo, the firm’s global LGBTQ+ network group.
He speaks English, French and German.
- Helping a healthcare company co-ordinate the defence of product liability claims and related regulatory enquiries in a large number of markets outside North America.
- Assisting a number of clients with investigations by the UK Competition and Markets Authority into alleged unfair sales, pricing and promotional practices.
- Advising a global pharma company on litigation and investigations management issues arising from a series of interlinked M&A transactions.
- Acting for a diagnostics products manufacturer in relation to false positive results produced by a hospital’s laboratory in the context of cancer screening, and defence against threatened legal action.
- Coordinating multi-j advice on the regulation of tech products and FMCG, including on the regulation of electronic cigarettes in 150+ markets and the regulatory classification of healthcare apps.
- University of Oxford, UK (modern languages)
- College of Law, Guildford, UK (CPE & LPC)
- British Institute for International and Comparative Law’s product liability forum
- European Commission Expert Group on Liability and New Technologies